Type 2 Diabetes
Conditions
Interventions
Gastrointestinal Reaction Group:None
Control group:None
Sponsors
Northern Jiangsu People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients with type 2 diabetes initiating semaglutide injection therapy;
Exclusion criteria
Exclusion criteria: 1.Patients who have used other GLP-1RA therapies (e.g., liraglutide, exenatide, lixisenatide, loxenatide, etc.) within the 3 months prior to initiating semaglutide injection treatment. 2.Patients with chronic gastrointestinal diseases presenting with symptoms such as nausea, vomiting, diarrhea, or loss of appetite. 3.Patients unable to provide symptom feedback, such as those with cognitive impairment. 4.Patients with adrenal insufficiency. 5.Non-diabetic individuals or patients with other types of diabetes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The starting dose;Alcohol drinking history;Transaminase;Sex;Glycated Hemoglobin (HbA1c);Age;Smoking history;Concomitant Medications;Serum Creatinine;Infection Status;Gastrointestinal Symptoms;Bilirubin;Body Mass Index (BMI); | — |
Countries
China
Contacts
Public ContactMao Leilei
Northern Jiangsu People's Hospital
Outcome results
None listed